Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific QMS Everolimus Assay Kit has been CE marked for sale in the European Union for a third application, namely liver transplants. This new indication allows laboratories to monitor blood levels of everolimus, the active ingredient in the drug Certican® (manufactured by Novartis Pharmaceuticals) in liver transplant patients. Previously, the QMS® Everolimus Assay Kit was CE marked for kidney and heart transplant applications. In the United States, the QMS Everolimus Assay Kit has U.S. Food and Drug Administration (FDA) clearance for use in monitoring kidney transplant patients. Thermo Fisher Scientific was the first company to offer a CE marked and FDA cleared assay for monitoring everolimus in kidney transplant patients.

The QMS® Everolimus Assay Kit rounds out Thermo Fisher Scientific's menu of immunoassays for immunosuppressant drugs including cyclosporine, tacrolimus, and mycophenolic acid.

Thermo Fisher Scientific has a proven track record for supplying high-quality reagents, calibrators and controls that dates back to 1989. The company's homogeneous immunoassay products have been used in many major clinical laboratories and drug testing facilities around the world. The ready-to-use, liquid QMS assays are used on automatic clinical chemistry analyzers as part of therapeutic drug monitoring, an integral part in organ transplant recipient treatment programs.

Thermo Scientific QMS Everolimus Calibrator and Control sets are also available for use with the QMS Everolimus Assay. The calibrator kit contains six different calibrators to complete a full six-point calibration as part of the test procedure; the QMS Everolimus Control Set contains three levels.

Source:

Thermo Fisher Scientific

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 24). Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application. News-Medical. Retrieved on August 05, 2021 from https://www.news-medical.net/news/20130116/Thermo-Scientific-QMS-Everolimus-Assay-Kit-receives-CE-Mark-for-liver-transplant-application.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application". News-Medical. 05 August 2021. <https://www.news-medical.net/news/20130116/Thermo-Scientific-QMS-Everolimus-Assay-Kit-receives-CE-Mark-for-liver-transplant-application.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application". News-Medical. https://www.news-medical.net/news/20130116/Thermo-Scientific-QMS-Everolimus-Assay-Kit-receives-CE-Mark-for-liver-transplant-application.aspx. (accessed August 05, 2021).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application. News-Medical, viewed 05 August 2021, https://www.news-medical.net/news/20130116/Thermo-Scientific-QMS-Everolimus-Assay-Kit-receives-CE-Mark-for-liver-transplant-application.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Thermo Scientific Smart-Vue Pro Remote Monitoring Solution supports optimal sample safety and integrity